Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biopharma News
Biosimilar Deals 2025
Biosimilar Deals 2026
Biosimilars Deals 2023
Biosimilars Deals 2024
Chantal Savage
Diversity
Helen Macpherson
Intranet
Kimberley Evans
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
Paul Johns
PipCast®
PTE
Trade Marks
Webinars

Pearce recognised as a World Leading IP Strategist by IAM Strategy 300

by | Jan 21, 2022

Pearce IP is proud to announce that Founding Principal and Executive Lawyer, Patent & Trade Mark Attorney, Naomi Pearce, has again been listed in the 2022 edition of IAM Strategy 300 Global Leaders.

The 300 listing is peer recognition of Pearce as one of the “top experts in the IP world”.  IAM describes “a slot in the 300” as “the mark of a professional whose approach to intellectual property is regarded by peers as truly strategic in nature”.

Special Counsel Jacinta Flattery-O’Brien says:

‘Naomi is expert at crafting elegant IP strategies for her clients.  This award is further recognition of her incredible talent, and is indicative of the strategic flare of the Pearce IP team.’

Pearce IP is a boutique firm offering intellectual property specialist lawyers, patent attorneys and trade mark attorneys to the pharmaceutical, biopharmaceutical and life sciences industries.

Pearce IP and its leaders, are well recognised as leading patent practitioners.  Pearce IP was awarded ‘Intellectual Property Team of the Year’ in the 2021 Lawyers Weekly Australian Law Awards, and is ranked in IAM Patent 1000 for both legal and attorney patent services.  Team members are listed in IAM Patent 1000 and IAM Strategy 300, have been awarded Patent Stars & Notable Practitioner listings by MIP, ranked in Doyles Guide, and listed in WIPR Leaders, 5 Star IP Lawyers, and Australasian Lawyer 5 Star Awards.  Naomi Pearce was also awarded “Partner of the Year (SME Law)” in the 2021 Lawyers Weekly Women in Law Awards.

Naomi Pearce

Naomi Pearce

CEO, Executive Lawyer (AU, NZ), Patent Attorney (AU, NZ) & Trade Mark Attorney (AU)

Naomi is the CEO and Founder of Pearce IP, and is one of ANZ’s leading IP practitioners. Naomi is a market leading, strategic, commercially astute, patent lawyer, patent attorney and trade mark attorney, with over 29 years’ experience, and a background in molecular biology/biochemistry.

Ranked in virtually every notable legal directory, highly regarded by peers and clients, Naomi is renowned for her successful and elegant IP/legal strategies focussing on complex/multijurisdictional litigation, global FTO, and strategic advice.  Among other awards, Naomi is the 2026 Lexology Client Choice Winner for Patents, the 2024 Lawyers Weekly Women in LawExecutive of the Year”, the 2023 Lawyers Weekly “IP Partner of the Year”, the 2022 Lexology Client Choice Winner for Life Sciences, the 2022 Asia Pacific Women in Business Law Patent Lawyer of the Year”, and the 2021 Lawyers Weekly Women in Law “Partner of the Year”.  Ranked in Chambers Asia Pacific, Chambers Global,  IAM Patent 1000IAM Strategy 300, is a MIP “Patent Star”, and is recognised as a WIPR Leader for patents and trade marks. 

Pearce IP is the premier life sciences focussed firm in ANZ.  Commencing in 2017. Pearce IP is the 2025 Australasian Lawyer and NZ Lawyer 5-Star Employer of Choice & “Standout Winner” for Inclusion and Culture (<100 employees).  In 2021, Pearce IP was the Lawyers Weekly Australian Law Awards IP Team of the Year.

Jacinta Flattery-O'Brien PhD

Jacinta Flattery-O'Brien PhD

Special Counsel, Patent Attorney

Jacinta is a trusted and recognised leader in biotech/pharma patenting, identified as an "IP Star" by the highly regarded Managing Intellectual Property Journal (MIP) for her expertise.

She is a registered patent attorney with 20 years' experience serving clients in the biotechnology, pharmaceutical and biopharmaceutical industries.

Get our Pearce IP Blogs & BioBlast® sent directly to your inbox

Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.